Bovie Medical Co. (NYSEAMERICAN:BVX) – Research analysts at Dougherty & Co lifted their FY2018 earnings per share (EPS) estimates for Bovie Medical in a report issued on Monday, November 5th. Dougherty & Co analyst K. Bauser now anticipates that the medical device company will post earnings per share of ($0.33) for the year, up from their previous forecast of ($0.38). Dougherty & Co currently has a “Buy” rating and a $11.00 target price on the stock. Dougherty & Co also issued estimates for Bovie Medical’s Q4 2018 earnings at ($0.10) EPS and FY2019 earnings at ($0.43) EPS.
Bovie Medical (NYSEAMERICAN:BVX) last posted its earnings results on Thursday, November 1st. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.08. The firm had revenue of $3.67 million during the quarter, compared to analyst estimates of $3.67 million. During the same quarter in the previous year, the business posted ($0.09) earnings per share. The business’s quarterly revenue was up 38.5% compared to the same quarter last year.
NYSEAMERICAN:BVX opened at $6.84 on Wednesday. Bovie Medical has a 1 year low of $2.28 and a 1 year high of $7.62.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. RTW Investments LP grew its position in Bovie Medical by 7.8% in the 2nd quarter. RTW Investments LP now owns 2,082,137 shares of the medical device company’s stock worth $9,057,000 after purchasing an additional 150,189 shares during the last quarter. Royce & Associates LP boosted its position in shares of Bovie Medical by 3.4% during the 2nd quarter. Royce & Associates LP now owns 710,000 shares of the medical device company’s stock valued at $3,088,000 after acquiring an additional 23,400 shares in the last quarter. Cortina Asset Management LLC boosted its position in shares of Bovie Medical by 5.4% during the 2nd quarter. Cortina Asset Management LLC now owns 658,528 shares of the medical device company’s stock valued at $2,865,000 after acquiring an additional 33,992 shares in the last quarter. Perkins Capital Management Inc. boosted its position in shares of Bovie Medical by 16.1% during the 3rd quarter. Perkins Capital Management Inc. now owns 465,350 shares of the medical device company’s stock valued at $3,304,000 after acquiring an additional 64,650 shares in the last quarter. Finally, Cowen Prime Services LLC boosted its position in shares of Bovie Medical by 10.3% during the 2nd quarter. Cowen Prime Services LLC now owns 348,093 shares of the medical device company’s stock valued at $1,514,000 after acquiring an additional 32,636 shares in the last quarter.
About Bovie Medical
Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue.
Featured Story: What is the 52-week high/low?
Receive News & Ratings for Bovie Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical and related companies with MarketBeat.com's FREE daily email newsletter.